Trial
NCT03507127
Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
—
Condition
Tobacco Dependence
Intervention
Varenicline
Why stopped
Low rate of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-17